Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.
Staphylococcus aureus is an important and prevalent cause of both uncomplicated bacteremia, as well as endocarditis. This article addresses the following controversial strategies: diagnosis of endocarditis in staphylococcemic populations; optimal treatment strategies for right-sided and left-sided S. aureus endocarditis; use of echocardiography in S. aureus endocarditis; and therapy options for catheter-associated staphylococcemias.
Mortara
L A
LA
Division of Adult Infectious Diseases, Harbor-University of California, Los Angeles Medical Center.
Bayer
A S
AS
D016470:Bacteremia / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000453:epidemiology; D006328:Cardiac Catheterization / Q000009:adverse effects; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D013203:Staphylococcal Infections / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000453:epidemiology; D013211:Staphylococcus aureus; D014640:Vancomycin / Q000627:therapeutic use
D014640:Vancomycin